Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: J Pain Symptom Manage. 2014 Aug 13;49(3):513–520. doi: 10.1016/j.jpainsymman.2014.06.011

Table 1.

Summary (median and range) of the Percentage of HSCT Recipients (n=30) Completing Daily Symptom Severity Survey, by Week Post-Transplant and by Post-Transplant Phase (Inpatient Hospitalization and Following First Post-Transplant Hospital Discharge)

Full Intensity
Allogeneic
(range)
Reduced
Intensity
Allogeneic
(range)
Autologousa
(range)
Overall
(range)
D0-D7 86 (43–100) 100 (57–100) 100 (29–100) 86 (29–100)
D8-D14 86 (29–100) 100 (43–100) 85 (14–100) 86 (14–100)
D15-D21 86 (0–100) 100 (57–100) - 86 (0–100)
D22-D50 48 (0–90) 90 (31–100) - 67 (0–100)
D51-D100 48 (0–96) 83 (0–100) - 70 (0–100)
Initial transplant hospitalization 70 (21–100) 87 (46–100) 94 (37–100) 86 (21–100)
Post-discharge 52 (0–87) 86 (46–100) - 70 (10–100)

Note: Denominators for allogeneic transplant patients are the first day of conditioning through 100 days following transplantation. The denominator for autologous transplant patients is the first day of conditioning through the day of discharge from the initial hospitalization

a

Autologous group did not complete daily reports following discharge.